Keyphrases
Medical Treatment
100%
Colorectal Cancer
100%
Irinotecan
66%
Clinical Practice
33%
Tumor
33%
Targeted Therapy
33%
Proteomics
33%
Difficult Problem
33%
Biological Evaluation
33%
Prescription Drugs
33%
Biologists
33%
Metabolomics
33%
Clinical Patients
33%
EGFR Inhibitors
33%
Cetuximab
33%
Individual Adaptation
33%
Metastatic Colorectal Cancer (mCRC)
33%
Angiogenesis Inhibitors
33%
Oxaliplatin
33%
Panitumumab
33%
UGT1A1
33%
Predictive Factors of Response
33%
Status Determination
33%
Last Five Years
33%
RAS Status
33%
Clinical Prescription
33%
Medicine and Dentistry
Combination Therapy
100%
Clinician
100%
Colorectal Cancer
100%
Irinotecan
66%
Neoplasm
33%
Targeted Therapy
33%
Predictive Factor
33%
Metabolomics
33%
Proteomics
33%
EGFR Inhibitors
33%
Metastatic Colorectal Cancer
33%
Angiogenesis Inhibitor
33%
Oxaliplatin
33%
Bioassay
33%
Cetuximab
33%
Panitumumab
33%
Pharmacology, Toxicology and Pharmaceutical Science
Colorectal Cancer
100%
Combination Therapy
100%
Irinotecan
66%
Bioassay
33%
Metastatic Colorectal Cancer
33%
Neoplasm
33%
Oxaliplatin
33%
Cetuximab
33%
Epidermal Growth Factor Receptor
33%
Angiogenesis Inhibitor
33%
Panitumumab
33%
Mathematics
Medical Treatment
100%
Ten Year
100%